Loading product details…Cargando detalles del producto…Carregando detalhes do produto…

At a glance

AGORESEARCH
Specification
Category
Form
Knowledge source
Research focus
Reconstitution
Storage
COA

What is BB10?

Repair blend profile pairing BPC-157 and TB-500. The LPPEPTIDE knowledge record describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. BPC 5mg + TB 5mg is mapped to LPPeptide SKU BB10. Current storefront values use our product data: 10mg x 10 vials /box, $98.00 USD per box. LPPeptide reference specs: 10mg x 10 vials (BPC-157 5mg + TB-500 5mg).

Research context

The LPPEPTIDE knowledge record describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. The fallback context pairs BPC-157 tissue and gut-barrier literature with TB-500 cell-migration and actin pathway literature.

Commonly matched with

BB10 is commonly reviewed alongside BC10, BB20, BT10, BBG70, BPC-157. Keep each combination tied to a defined research objective and lot record.

Compliance notice

BB10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. The fallback context pairs BPC-157 tissue and gut-barrier literature with TB-500 cell-migration and actin pathway literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 10mg x 10 vials (BPC-157 5mg + TB-500 5mg).

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: reconstitute TB-500 with 2.0 mL bacteriostatic water for 2.5 mg/mL and BPC-157 with 2.0 mL for 2.5 mg/mL. Reference notes list TB-500 at 1,250 mcg twice weekly in weeks 1-4 then weekly, and BPC-157 at 250-500 mcg daily; 1 U equals 25 mcg at 2.5 mg/mL.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

BPC 5mg + TB 5mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: reconstitute TB-500 with 2.0 mL bacteriostatic water for 2.5 mg/mL and BPC-157 with 2.0 mL for 2.5 mg/mL. Reference notes list TB-500 at 1,250 mcg twice weekly in weeks 1-4 then weekly, and BPC-157 at 250-500 mcg daily; 1 U equals 25 mcg at 2.5 mg/mL.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C, dry and dark. Reconstituted: 2-8 deg C, protect from light, and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Combination data is narrower than single-compound data. Document tolerability signals and avoid extrapolating from either component alone.

Contraindications

Do not use BB10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review any additional stacking with GHK-Cu, KPV, or growth-hormone-axis materials before study design approval.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps BB10 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: BB10
  • Product: BPC 5mg + TB 5mg
  • Storefront specification: 10mg x 10 vials /box
  • LPPeptide reference specs: 10mg x 10 vials (BPC-157 5mg + TB-500 5mg)
  • Listed box price: $98.00 USD
  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity
  • HPLC purity or assay result where applicable
  • Batch ID and test date
  • Sterility/endotoxin or accessory checks when applicable
  • Residual solvent and handling notes where applicable
About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is BB10?

Repair blend profile pairing BPC-157 and TB-500. Coze describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. BPC 5mg + TB 5mg is mapped to LPPeptide SKU BB10. Current storefront values use our product data: 10mg x 10 vials /box, $98.00 USD per box. LPPeptide reference specs: 10mg x 10 vials (BPC-157 5mg + TB-500 5mg).

Research context

Coze describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. The fallback context pairs BPC-157 tissue and gut-barrier literature with TB-500 cell-migration and actin pathway literature.

Commonly matched with

BB10 is commonly reviewed alongside BC10, BB20, BT10, BBG70, BPC-157. Keep each combination tied to a defined research objective and lot record.

Compliance notice

BB10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

Coze describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. The fallback context pairs BPC-157 tissue and gut-barrier literature with TB-500 cell-migration and actin pathway literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 10mg x 10 vials (BPC-157 5mg + TB-500 5mg).

Dosing & Protocol

LPPeptide handling reference

Coze source: reconstitute TB-500 with 2.0 mL bacteriostatic water for 2.5 mg/mL and BPC-157 with 2.0 mL for 2.5 mg/mL. Reference notes list TB-500 at 1,250 mcg twice weekly in weeks 1-4 then weekly, and BPC-157 at 250-500 mcg daily; 1 U equals 25 mcg at 2.5 mg/mL. Coze preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

BPC 5mg + TB 5mg ships as Lyophilized powder. Reconstitution note: Coze source: reconstitute TB-500 with 2.0 mL bacteriostatic water for 2.5 mg/mL and BPC-157 with 2.0 mL for 2.5 mg/mL. Reference notes list TB-500 at 1,250 mcg twice weekly in weeks 1-4 then weekly, and BPC-157 at 250-500 mcg daily; 1 U equals 25 mcg at 2.5 mg/mL.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C, dry and dark. Reconstituted: 2-8 deg C, protect from light, and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Combination data is narrower than single-compound data. Document tolerability signals and avoid extrapolating from either component alone.

Contraindications

Do not use BB10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review any additional stacking with GHK-Cu, KPV, or growth-hormone-axis materials before study design approval.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps BB10 visible so the SKU can be matched to the active COA.

Current catalog summary

- SKU: BB10 - Product: BPC 5mg + TB 5mg - Storefront specification: 10mg x 10 vials /box - LPPeptide reference specs: 10mg x 10 vials (BPC-157 5mg + TB-500 5mg) - Listed box price: $98.00 USD - Reference: LPPeptide product knowledge record

Testing checklist

- Peptide identity or material identity - HPLC purity or assay result where applicable - Batch ID and test date - Sterility/endotoxin or accessory checks when applicable - Residual solvent and handling notes where applicable

About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.

What is BB10?

Repair blend profile pairing BPC-157 and TB-500. Coze describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. BPC 5mg + TB 5mg is mapped to LPPeptide SKU BB10. Current storefront values use our product data: 10mg x 10 vials /box, $98.00 USD per box. LPPeptide reference specs: 10mg x 10 vials (BPC-157 5mg + TB-500 5mg).

Research context

Coze describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. The fallback context pairs BPC-157 tissue and gut-barrier literature with TB-500 cell-migration and actin pathway literature.

Commonly matched with

BB10 is commonly reviewed alongside BC10, BB20, BT10, BBG70, BPC-157. Keep each combination tied to a defined research objective and lot record.

Compliance notice

BB10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

Coze describes the BPC + TB combination as a synergistic repair-support research blend: TB-500 is reviewed for angiogenesis and cell migration, while BPC-157 is reviewed for growth-factor signaling and musculoskeletal repair models. The fallback context pairs BPC-157 tissue and gut-barrier literature with TB-500 cell-migration and actin pathway literature.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 10mg x 10 vials (BPC-157 5mg + TB-500 5mg).

Dosing & Protocol

LPPeptide handling reference

Coze source: reconstitute TB-500 with 2.0 mL bacteriostatic water for 2.5 mg/mL and BPC-157 with 2.0 mL for 2.5 mg/mL. Reference notes list TB-500 at 1,250 mcg twice weekly in weeks 1-4 then weekly, and BPC-157 at 250-500 mcg daily; 1 U equals 25 mcg at 2.5 mg/mL. Coze preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

BPC 5mg + TB 5mg ships as Lyophilized powder. Reconstitution note: Coze source: reconstitute TB-500 with 2.0 mL bacteriostatic water for 2.5 mg/mL and BPC-157 with 2.0 mL for 2.5 mg/mL. Reference notes list TB-500 at 1,250 mcg twice weekly in weeks 1-4 then weekly, and BPC-157 at 250-500 mcg daily; 1 U equals 25 mcg at 2.5 mg/mL.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C, dry and dark. Reconstituted: 2-8 deg C, protect from light, and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Combination data is narrower than single-compound data. Document tolerability signals and avoid extrapolating from either component alone.

Contraindications

Do not use BB10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review any additional stacking with GHK-Cu, KPV, or growth-hormone-axis materials before study design approval.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps BB10 visible so the SKU can be matched to the active COA.

Current catalog summary

- SKU: BB10 - Product: BPC 5mg + TB 5mg - Storefront specification: 10mg x 10 vials /box - LPPeptide reference specs: 10mg x 10 vials (BPC-157 5mg + TB-500 5mg) - Listed box price: $98.00 USD - Reference: LPPeptide product knowledge record

Testing checklist

- Peptide identity or material identity - HPLC purity or assay result where applicable - Batch ID and test date - Sterility/endotoxin or accessory checks when applicable - Residual solvent and handling notes where applicable

About LPPeptide

Direct catalog supply

LPPeptide product pages use our own SKU, package, price, and stock data first. LPPeptide knowledge mapping adds compound education, handling notes, and specification checks while lot-specific editorial content is being prepared.

Lot-specific content

For final release decisions, use the current product record, COA, handling sheet, and research SOP as the highest-priority source for this page.